These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis. Park Y, Lee EH, Jung I, Park G, Kang YA. Respir Res; 2019 Dec 18; 20(1):286. PubMed ID: 31852452 [Abstract] [Full Text] [Related]
7. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520 [Abstract] [Full Text] [Related]
10. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin. Jarand J, Davis JP, Cowie RL, Field SK, Fisher DA. Chest; 2016 May 01; 149(5):1285-93. PubMed ID: 26513209 [Abstract] [Full Text] [Related]
14. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014. Lee MR, Chien JY, Huang YT, Liao CH, Shu CC, Yu CJ, Hsueh PR. Int J Antimicrob Agents; 2017 Jul 27; 50(1):35-40. PubMed ID: 28478210 [Abstract] [Full Text] [Related]
16. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease. Kim HJ, Lee JS, Kwak N, Cho J, Lee CH, Han SK, Yim JJ. BMC Pulm Med; 2019 Nov 11; 19(1):212. PubMed ID: 31711459 [Abstract] [Full Text] [Related]